Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Recordati

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Recordati's 2013 sales performance.

Deal Watch July 2016

Deal Watch July 2016 BioD. $21.3 plus $56.5 contingent. $22m. 3.5x. N/A. Recordati. Pro Farma. ... Recordati has been busy on the acquisition front recently; in May the company acquired Italichimici for $145m, strengthening its gastroenterology and respiratory ranges, and

Recordati snaps up Swiss pharma company Pro Farma

Recordati snaps up Swiss pharma company Pro Farma Recordati's burgeoning gastroenterology pipeline will also receive a boost from the transaction thanks to the addition of lactose intolerance drug Lacdigest (tilactase). ... Italchimici acquisition. Meanwhile, Recordati finalised a 130m deal to buy

Takeda grows in Turkey with Neutec subsidiary acquisition

Takeda grows in Turkey with Neutec subsidiary acquisition Other companies investing in Turkey of late include Amgen - which bought local producer Mustafa Nevzat in 2012 for $700m - while Sanofi, Otsuka and Recordati are among companies building manufacturing capacity in

Campaigns recognised at German health comms awards

Campaigns recognised at German health comms awards The agency won in the category for prescription medicines for its campaign for muscle relaxant Ortoton, which is produced by Recordati.

Turkey aims to become ‘global player’ in biopharma

Turkey aims to become ‘global player’ in biopharma Meanwhile, Sanofi, Otsuka and most recently Recordati have been building manufacturing capacity in Turkey, and this sort of inward investment is exactly what the country's industry needs, according to the

[ Previous 5 results ] 1 2 3 4 5 6 7 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Nobull Communications

Switched on Creative Communications. With an encyclopedic working knowledge of pharmaceutical industry rules and regulations, we create dynamic, intuitive and...

Latest intelligence

The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
How is the NHS Long-term Plan being put into action?
Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...
real world studies
The evolution of real-world studies
How industry and regulators are using real-world data...

Infographics